Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 58 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-16 Makhzoumi Mohamad 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 Florence Anthony A. Jr. 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 Chang Carmen 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 Behbahani Ali 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 BASKETT FOREST 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 New Enterprise Associates 16, L.P. 10% owner Purchase +5,714,285 $1.75 $10.0M 10,714,285
2021-03-16 Wilson John Robert Director Purchase +1,714,285 $1.75 $3.0M 7,799,350
2021-03-16 Vera Juan Chief Development Officer Purchase +571,428 $1.75 $1000K 2,564,487
2021-03-16 Hoang Peter L. President and CEO Purchase +142,857 $1.75 $250K 332,568
2021-03-16 ELMS STEVE Director Purchase +1,142,857 $1.75 $2.0M 3,142,857
2021-02-11 Hoang Peter L. President and CEO Grant or award · Employee Stock Option (right to buy) +430,000 430,000
2021-02-10 Vera Juan Chief Development Officer Grant or award · Employee Stock Option (right to buy) +140,000 140,000
2021-02-10 Szymanska Anna Vice President, Quality Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2021-02-10 Loiacono Michael Chief Accounting Officer Grant or award · Employee Stock Option (right to buy) +140,000 140,000
2021-02-10 Koneru Mythili Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +140,000 140,000
2021-02-10 Kim Anthony H. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +160,000 160,000
2021-02-10 Hoang Tsvetelina P VP, Research and Development Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2021-02-10 Garrett Gerald Vice President, Clinical Ops. Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2021-02-10 Agopyan Nadia VP, Regulatory Affairs Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2020-06-16 Eastern Capital LTD 10% owner Other disposition · Series E-1 Warrant −416,667 0

Page 4 of 6 · 119 trades